Skip to main content
SpringerLink
Log in

Einfluss von Spironolacton auf die Belastungskapazität von Patienten mit diastolischer Dysfunktion

Influence of spironolactone on the load capacity of patients with diastolic dysfunction

  • Journal Club
  • Published:
Der Kardiologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. McMurray JJ, Adamopoulos S, Anker SD et al (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14:803–869

    Article  PubMed  CAS  Google Scholar 

  2. Zannad F, Gattis Stough W, Rossignol P et al (2012) Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice. Eur Heart J 33:2782–2795

    Article  PubMed  CAS  Google Scholar 

  3. Pitt B, Zannad F, Remme WJ et al (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341:709–717

    Article  PubMed  CAS  Google Scholar 

  4. Zannad F, McMurray JJ, Krum H et al (2011) Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364:11–21

    Article  PubMed  CAS  Google Scholar 

  5. Cleland JG, Pellicori P (2013) Defining diastolic heart failure and identifying effective therapies. JAMA 309:825–826

    Article  PubMed  CAS  Google Scholar 

  6. Patel K, Fonarow GC, Kitzman DW et al (2013) Aldosterone antagonists and outcomes in real-world older patients with heart failure and preserved ejection fraction. JACC Heart Fail 1:40–47

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

C. Özcelik gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Herzverbund Südniedersachsen, Helios Albert-Schweitzer-Klinik, Sturmbäume 8, 37154, Northeim, Deutschland

    C. Özcelik

Authors
  1. C. Özcelik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Özcelik.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Özcelik, C. Einfluss von Spironolacton auf die Belastungskapazität von Patienten mit diastolischer Dysfunktion. Kardiologe 7, 407–409 (2013). https://doi.org/10.1007/s12181-013-0533-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12181-013-0533-0

Search

Navigation